vs

Side-by-side financial comparison of Ballard Power Systems Inc. (BLDP) and Verastem, Inc. (VSTM). Click either name above to swap in a different company.

Ballard Power Systems Inc. is the larger business by last-quarter revenue ($17.7M vs $11.2M, roughly 1.6× Verastem, Inc.). Ballard Power Systems Inc. runs the higher net margin — 994.4% vs -876.3%, a 1870.8% gap on every dollar of revenue.

Ballard Power Systems Inc. is a developer and manufacturer of proton exchange membrane (PEM) fuel cell products for markets such as heavy-duty motive, portable power, material handling as well as engineering services. Ballard has designed and shipped over 400 MW of fuel cell products to date.

Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.

BLDP vs VSTM — Head-to-Head

Bigger by revenue
BLDP
BLDP
1.6× larger
BLDP
$17.7M
$11.2M
VSTM
Higher net margin
BLDP
BLDP
1870.8% more per $
BLDP
994.4%
-876.3%
VSTM

Income Statement — Q3 FY2025 vs Q3 FY2025

Metric
BLDP
BLDP
VSTM
VSTM
Revenue
$17.7M
$11.2M
Net Profit
$176.5M
$-98.5M
Gross Margin
Operating Margin
-362.2%
Net Margin
994.4%
-876.3%
Revenue YoY
Net Profit YoY
-311.1%
EPS (diluted)
$-1.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BLDP
BLDP
VSTM
VSTM
Q3 25
$17.7M
$11.2M
Q2 25
$2.1M
Q3 24
$-12.3M
$0
Q2 24
$10.0M
Q1 22
$3.4M
Net Profit
BLDP
BLDP
VSTM
VSTM
Q3 25
$176.5M
$-98.5M
Q2 25
$-25.9M
Q3 24
$-24.0M
Q2 24
$-8.3M
Q1 22
$-22.6M
Gross Margin
BLDP
BLDP
VSTM
VSTM
Q3 25
Q2 25
Q3 24
156.5%
Q2 24
Q1 22
Operating Margin
BLDP
BLDP
VSTM
VSTM
Q3 25
-362.2%
Q2 25
-2047.9%
Q3 24
Q2 24
-182.8%
Q1 22
Net Margin
BLDP
BLDP
VSTM
VSTM
Q3 25
994.4%
-876.3%
Q2 25
-1213.6%
Q3 24
Q2 24
-82.6%
Q1 22
-659.1%
EPS (diluted)
BLDP
BLDP
VSTM
VSTM
Q3 25
$-1.35
Q2 25
$-0.62
Q3 24
$-0.60
Q2 24
$-0.31
Q1 22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BLDP
BLDP
VSTM
VSTM
Cash + ST InvestmentsLiquidity on hand
$137.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$-15.5M
Total Assets
$176.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BLDP
BLDP
VSTM
VSTM
Q3 25
$137.7M
Q2 25
$164.3M
Q3 24
$113.2M
Q2 24
$83.4M
Q1 22
Total Debt
BLDP
BLDP
VSTM
VSTM
Q3 25
Q2 25
Q3 24
$40.5M
Q2 24
$40.3M
Q1 22
Stockholders' Equity
BLDP
BLDP
VSTM
VSTM
Q3 25
$-15.5M
Q2 25
$36.1M
Q3 24
$11.1M
Q2 24
$18.9M
Q1 22
Total Assets
BLDP
BLDP
VSTM
VSTM
Q3 25
$176.9M
Q2 25
$196.3M
Q3 24
$126.4M
Q2 24
$105.7M
Q1 22
Debt / Equity
BLDP
BLDP
VSTM
VSTM
Q3 25
Q2 25
Q3 24
3.66×
Q2 24
2.14×
Q1 22

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BLDP
BLDP
VSTM
VSTM
Operating Cash FlowLast quarter
$5.7M
$-36.2M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.03×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BLDP
BLDP
VSTM
VSTM
Q3 25
$5.7M
$-36.2M
Q2 25
$-32.7M
Q3 24
$-6.6M
$-23.8M
Q2 24
$-27.6M
Q1 22
$-26.0K
Free Cash Flow
BLDP
BLDP
VSTM
VSTM
Q3 25
Q2 25
Q3 24
Q2 24
$-27.6M
Q1 22
FCF Margin
BLDP
BLDP
VSTM
VSTM
Q3 25
Q2 25
Q3 24
Q2 24
-275.8%
Q1 22
Capex Intensity
BLDP
BLDP
VSTM
VSTM
Q3 25
Q2 25
Q3 24
Q2 24
0.1%
Q1 22
Cash Conversion
BLDP
BLDP
VSTM
VSTM
Q3 25
0.03×
Q2 25
Q3 24
Q2 24
Q1 22

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons